Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study

Cancer Genetics

Volumn 205, Issue 6, 2012, Pages 278-284

  Pavanello, Sofia ^a   Fedeli, Ugo ^b   Mastrangelo, Giuseppe ^a   Rota, Federica ^c   Overvad, Kim ^d   Raaschou Nielsen, Ole ^e   Tjønneland, Anne ^e   Vogel, Ulla ^f,g  

^a UNIVERSITY OF PADOVA   (Italy)

^b Sistema Epidemiologico Regione Veneto (SER)   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d AARHUS UNIVERSITY   (Denmark)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^g ROSKILDE UNIVERSITY   (Denmark)

Author keywords

Carcinogen exposure; CYP1A2 polymorphism; Europeans; Inflammation; Lung cancer; Prospective study

Indexed keywords

ADENINE; CYTOCHROME P450 1A2; CYTOSINE; GUANINE; THYMINE; CYP1A2 PROTEIN, HUMAN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYP1A2 GENE; DENMARK; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD INTAKE; FRUIT; GENE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFESTYLE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MEAT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX RATIO; SMOKING HABIT; VEGETABLE; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK; SMOKING;

EID: 84865853822     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.02.004     Document Type: Article

References (48)

1. Zhou S.F., Wang B., Yang L.P., et al. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 2010, 42:268-354.
2. Landi M.T., Sinha R., Lang N.P., et al. Chapter 16. Human cytochrome P4501A2. Metabolic polymorphisms and susceptibility to cancer 1999, 148:173-195. IARC Scientific Publications, IARC, Lyon. P. Vineis, N. Malats, M. Lang (Eds.).
3. Bartsch H., Nair U., Risch A., et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000, 9:3-28.
4. Nebert D.W., Dalton T.P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006, 6:947-960.
5. Sesardic D., Boobis A.R., Edwards R.J., et al. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol 1988, 26:363-372.
6. Chung W.G., Kang J.H., Park C.S., et al. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism. Clin Pharmacol Ther 2000, 67:258-266.
7. Nordmark A., Lundgren S., Cnattingius S., et al. Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples. Br J Clin Pharmacol 1999, 47:397-402.
8. Djordjevic N., Ghotbi R., Bertilsson L., et al. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur J Clin Pharmacol 2008, 64:381-385.
9. Landi M.T., Zocchetti C., Bernucci I., et al. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 1996, 5:693-698.
10. Pavanello S., Pulliero A., Lupi S., et al. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat Res 2005, 587:59-66.
11. Gunes A., Ozbey G., Vural E.H., et al. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population. Pharmacogenomics 2009, 10:769-778.
12. Sachse C., Brockmöller J., Bauer S., et al. Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999, 47:445-449.
13. Ghotbi R., Christensen M., Roh H.K., et al. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol 2007, 63:537-546.
14. Pavanello S., Simioli P., Lupi S., et al. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers. Cancer Epidemiol Biomarkers Prev 2002, 11:998-1003.
15. Pavanello S., B'chir F., Pulliero A., et al. Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung. Lung Cancer 2007, 57:266-272.
16. Pavanello S., Mastrangelo G., Placidi D., et al. CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer. Eur J Epidemiol 2010, 25:491-500.
17. Aldrich M.C., Selvin S., Hansen H.M., et al. CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification. Cancer Res 2009, 69:2340-2348.
18. DeVita V.T.J., Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology 2005, Lippincott Williams & Wilkins, Philadelphia. 8th ed.
19. Consonni D., De Matteis S., Lubin J.H., et al. Lung cancer and occupation in a population-based case-control study. Am J Epidemiol 2010, 171:323-333.
20. Samet J.M., Avila-Tang E., Boffetta P., et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009, 15:5626-5645.
21. Tasevska N., Sinha R., Kipnis V., et al. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 2009, 89. 1884-1194.
22. Lam T.K., Cross A.J., Consonni D., et al. Intakes of red meat, processed meat, and meat mutagens increase lung cancer risk. Cancer Res 2009, 69:932-939.
23. Bagnardi V., Randi G., Lubin J., et al. Alcohol consumption and lung cancer risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) study. Am J Epidemiol 2010, 171:36-44.
24. Olivo-Marston S.E., Yang P., Mechanic L.E., et al. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18:3375-3383.
25. Sidorchuk A., Agardh E.E., Aremu O., et al. Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control 2009, 20:459-471.
26. Mantovani A. The yin-yang of tumor-associated neutrophils. Cancer Cell 2009, 16:173-174.
27. Tjonneland A., Olsen A., Boll K., et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007, 35:432-441.
28. Storm H.H., Michelsen E.V., Clemmensen I.H., Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997, 44:535-539.
29. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
30. Barlow W.E., Ichikawa L., Rosner D., et al. Analysis of case-cohort designs. J Clin Epidemiol 1999, 52:1165-1172.
31. Raaschou-Nielsen O., Sørensen M., Hansen R.D., et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett 2007, 247:293-300.
32. Cheung Y.B., Gao F., Khoo K.S. Age at diagnosis and the choice of survival analysis methods in cancer epidemiology. J Clin Epidemiol 2003, 56:38-43.
33. Sørensen M., Raaschou-Nielsen O., Hansen R., et al. Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic Res 2006, 40:885-891.
34. Raaschou-Nielsen O., Sørensen M., Overvad K., et al. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 2008, 59:171-179.
35. Quattrochi L.C., Vu T., Tukey R.H. The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction. J Biol Chem 1994, 269:6949-6954.
36. Sogawa K., Fujii-Kuriyama Y. Ah receptor, a novel ligand-activated transcription factor. J Biochem 1997, 122:1075-1079.
37. Hankinson O. The aryl hydrocarbon receptor complex. Annual Rev Pharmacol Toxicol 1995, 35:307-340.
38. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991, 110:559-565.
39. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 2002, 181-182:457-462.
40. Pavanello S., Simioli P., Carrieri M., et al. Tobacco-smoke exposure indicators and urinary mutagenicity. Mutat Res 2002, 521:1-9.
41. Taioli E., Wynder E.L. Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994, 86:869-870.
42. Ganti A.K., Sahmoun A.E., Panwalkar A.W., et al. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006, 24:59-63.
43. Lin P.I., Vance J.M., Pericak-Vance M.A., et al. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007, 80:531-538.
44. Aklillu E., Carrillo J.A., Makonnen E., et al. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with singlenucleotide polymorphisms in intron 1. Mol Pharmacol 2003, 64:659-669.
45. Andersen V., Christensen J., Overvad K., et al. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010, 10:484.
46. Vogel U., Segel S., Tjønneland A., et al. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Atherosclerosis 2010, 209:155-162.
47. Vogel U., Segel S., Tjønneland A., et al. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes. BMC Med Genet 2009, 10:52.
48. Jensen M.K., Rimm E.B., Mukamal K.J., et al. The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 2009, 30:1584-1589.